Ventricular water absorption capacity in hydrocephalus

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519933-53-00

Acronym

455136

Enrollment

100

Registered

2025-01-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult hydrocephalus

Brief summary

From venous blood-samples during ventricular 15-oxygen-water infusion testing establish population pharmacokinetic measures of ventricular water absorption capacity on the individual basis.

Detailed description

Image the ventricular water absorption to brain using positron emission tomography (PET) imaging. for communicating and non-communicating hydrocephalus. Endpoints of safety and tolerability are defined as increase in intracranial pressure and symptoms of intracranial hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
From venous blood-samples during ventricular 15-oxygen-water infusion testing establish population pharmacokinetic measures of ventricular water absorption capacity on the individual basis.	—

Secondary

Measure	Time frame
Image the ventricular water absorption to brain using positron emission tomography (PET) imaging. for communicating and non-communicating hydrocephalus. Endpoints of safety and tolerability are defined as increase in intracranial pressure and symptoms of intracranial hypertension	—

Countries

Norway

Outcome results